Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tabernero

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2015
Proven efficacy, equitable access, and adjusted pricing of anti-cancer therapies: no 'sweetheart' solutionJ Tabernero,
ESMO Open|September 3, 2021
Corrigendum to 'Remembering Professor José Baselga': [ESMO Open Volume 6, Issue 3, June 2021, 100121]J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Core business, future direction, and the 10-bar targetJ Tabernero,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
CardiotoxicityI Brana, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2019
Value assessment frameworks in oncology: championing concordance through shared standardsM Bertagnolli, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time?D Páez, R Salazar, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumoursE Elez, T Macarulla, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2021
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelinesA Grothey, M Fakih, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Antiangiogenic therapies in gastric cancer: trusting the pathwayM Alsina, C Hierro, J Tabernero
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 15, 2012
Depicting the evolving scenario of translational-guided drug developmentG Argilés, J Rodon, J Tabernero
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2015
Proven efficacy, equitable access, and adjusted pricing of anti-cancer therapies: no 'sweetheart' solutionJ Tabernero,
ESMO Open|September 3, 2021
Corrigendum to 'Remembering Professor José Baselga': [ESMO Open Volume 6, Issue 3, June 2021, 100121]J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Core business, future direction, and the 10-bar targetJ Tabernero,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
CardiotoxicityI Brana, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2019
Value assessment frameworks in oncology: championing concordance through shared standardsM Bertagnolli, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time?D Páez, R Salazar, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumoursE Elez, T Macarulla, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2021
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelinesA Grothey, M Fakih, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Antiangiogenic therapies in gastric cancer: trusting the pathwayM Alsina, C Hierro, J Tabernero
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 15, 2012
Depicting the evolving scenario of translational-guided drug developmentG Argilés, J Rodon, J Tabernero
Pageof 21